Growth Metrics

Merck (MRK) EBT Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4,960.00
Dec 31, 2025 4,410.00
Sep 30, 2025 1,428.00
Jun 30, 2025 232.00
Mar 31, 2025 618.00
Dec 31, 2024 6,289.00
Sep 30, 2024 562.00
Jun 30, 2024 956.00
Mar 31, 2024 759.00
Dec 31, 2023 -3,766.00
Sep 30, 2023 1,052.00
Jun 30, 2023 -5,518.00
Mar 31, 2023 1,179.00
Dec 31, 2022 739.00
Sep 30, 2022 2,202.00
Jun 30, 2022 619.00
Mar 31, 2022 934.00
Dec 31, 2021 4,232.00
Sep 30, 2021 1,263.00
Jun 30, 2021 -22.00
Mar 31, 2021 1,067.00
Dec 31, 2020 -3,123.00
Sep 30, 2020 96.00
Jun 30, 2020 2,106.00
Mar 31, 2020 1,718.00
Dec 31, 2019 -14,888.00
Sep 30, 2019 482.00
Jun 30, 2019 1,042.00
Mar 31, 2019 798.00
Dec 31, 2018 1,286.00
Sep 30, 2018 1,087.00
Jun 30, 2018 863.00
Mar 31, 2018 -112.00
Dec 31, 2017 664.00
Sep 30, 2017 -1,737.00
Jun 30, 2017 279.00
Mar 31, 2017 -14.00
Dec 31, 2016 -2,627.00
Sep 30, 2016 784.00
Jun 30, 2016 152.00
Mar 31, 2016 251.00
Dec 31, 2015 2,333.00
Sep 30, 2015 1,932.00
Jun 30, 2015 -269.00
Mar 31, 2015 901.00
Dec 31, 2014 -1,583.00
Sep 30, 2014 400.00
Jun 30, 2014 419.00
Mar 31, 2014 -61.00